
ABOUT IQVIA TECHNOLOGIES
IQVIA Technologies develops purpose-built solutions on a future-state architecture to enable connected intelligence across the entire life sciences product lifecycle. Under our Orchestrated Clinical Trials (OCT) platform, we’re driving smarter, faster trials for sponsors, sites and patients, with more than 20 market-leading, cloud-based products and tech-enabled services. These best-of-breed technologies are grouped as Digital Suites and are available independently of our CRO services, with support models customized to meet your specific business needs.
FEATURED CONTENT
-
In this article, consider three key functions that an eTMF must have to achieve compliance and maintain organizational success.
-
Download this guide for 5 key recommendations on how to build an eCOA strategy in your next oncology trial that keeps your patient's voice front and center in their care.
-
Dive into how the shift to patient reported outcomes has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool in the clinical research landscape.
-
Once sponsors add eCOAs in DCTs and hybrid trials, a common question emerges: Can patients reliably complete eCOAs on their personal devices?
-
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
Dive into considerations when deciding on the best COAs to implement as well as best practices when developing your eCOA strategy in this blog.
-
Learn how the benefits of real time insight can help sponsors create safer trials, while providing financial and strategic benefits that may give them an edge in the marketplace.
-
Explore how COVID-19 opened the door for patients to use their own personal devices to record trial data and gave sponsors the nudge they needed to support a BYOD (bring your own device) approach to data collection.
-
By doing UAT in real time, discover how this ensures full alignment of the functionality and design within a clinical trial assessment.
-
eCOAs transform the paper-based assessment into a real-time digital tool that collects insights directly from the patient about their disease, the trial experience, and the treatment’s impact on their quality of life. Learn why this brings several immediate benefits.
-
The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
-
Find out how the shift towards a more patient-centric drug development landscape has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.
-
Explore how the use of electronic Clinical Outcomes Assessments (eCOAs) can be rapidly implemented to capture patient reported outcomes (PROs).
-
Scott Askin paints the picture of why Novartis, determined to improve the patient experience, has begun to deploy eConsent, and what they’ve learned along the way.
-
Learn about some insights that have been gleaned from experience deploying eConsent on diverse trial types around the world.
-
Explore how data science and artificial intelligence / machine learning (AI/ML) driven predictive and prescriptive insights can help research teams cut the time and cost.
-
Risk-Based Quality Management (RBQM) has been evolving into a mainstream choice for the critical monitoring aspect of clinical trials. Discover this evolution in the available white paper.
-
Clinical trials are evolving due to multiple forces that are affecting what was once a very standard approach. This notion of change has been constantly streaming into monitoring processes and the clinical monitoring role.
-
In this case study, learn about the challenges and solutions biopharmaceutical industry sponsors worked through to digitally enable sites and speed time to first-patient-in for COVID-19 therapeutic and vaccine trials.
-
Cenduit IRT study design teams took on the challenges pressing biopharmaceutical industry sponsors as they worked to digitally enable sites and speed time to first-patient-in for COVID-19 therapeutic and vaccine trials.
-
Year after year, slow and unpredictable investigator payments continue to be a top complaint from clinical study sites. Explore Bayer's Automated Site Payment Invoice Resolution project in the available white paper.
-
When Alnylam Pharmaceuticals began development of medicines for rare diseases with few or no treatment options, the company’s leaders knew they needed to design clinical trials that kept patient well-being and disease burden at the forefront. As Alnylam’s first clinical program began in 2014, the study team saw emerging site-facing technologies as a foundation for those trusted relationships, starting with a purpose-built communication channel and easy-to-use study conduct tools to support a complex protocol.
-
Two of America’s greatest assets are its diverse demographics and its relentless pursuit of new medicines and treatments. Unfortunately, it’s a widely known challenge that the two do not go hand in hand. Understand why minority participation in clinical trials is staggeringly deficient in this case study.
-
A Top 5 global pharmaceutical company wanted to help sites do everyday tasks more efficiently, making it easier for site staff to adhere to the protocol and deliver high-quality data. After evaluations and pilots, the company deployed IQVIA Technologies’ Investigator Site Portal (formerly DrugDev) in a 4-phase approach that delivered benefits each step of the way.
-
Conducting feasibility is an essential and necessary step to starting up a clinical trial. The good news is that the whole approach has the ability to change for the better by initiating and adopting some enhancements.
-
With so much new and updated information being shared on nearly a daily basis, it’s important to consider the most effective methods of organization and distribution. Here are some best practices we’ve compiled from working with sponsors and sites of all sizes and specialties during the COVID-19 pandemic.
CONTACT INFORMATION
IQVIA Technologies
4820 Emperor Blvd
Durham, NC 27703
UNITED STATES
Phone: 1-888-336-3748
Contact: Turquiose Ross, MBA
WEBINARS
-
In this webinar, eCOA experts will explore how to implement a BYOD strategy, relevant BYOD regulatory considerations, and where the market is going from here.
-
In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.
-
In this webinar, we will be exploring how to manage a supply chain through IRT with self service tools and actionable insights as well as best practices for supply forecasting and overstock management.
-
Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies on a collaborative portal more than 6 years ago and leveraging technology to deliver results.